Read + Share
Amedeo Smart
Independent Medical Education
Cutler CS, Lee SJ, Arai S, Rotta M, et al. Belumosudil for Chronic Graft-versus-Host Disease (cGVHD) After 2 or More Prior Lines of Therapy: The ROCKstar Study. Blood 2021 Jul 15. pii: 476399. doi: 10.1182/blood.2021012021.PMID: 34265047
Email
LinkedIn
Facebook
Twitter
Privacy Policy